tiprankstipranks
Trending News
More News >
Paradigm Biopharmaceuticals Ltd. (AU:PAR)
ASX:PAR

Paradigm Biopharmaceuticals (PAR) Revenue

Compare
22 Followers

Paradigm Biopharmaceuticals Revenue

Paradigm Biopharmaceuticals had a revenue of 16.70K in the quarter ending Dec 31, 2024, with -74.62%. This bring the company's revenue in the last twelve months to 82.50K, Decreased 25.38%. In the fiscal year ending Jun 30, 2024, Paradigm Biopharmaceuticals had annual revenue of 65.80K with 40.72% growth.
Revenue (ttm)
82.50K
Revenue Growth
96.20%
P/S Ratio
1864.29
Revenue/Employee
Employees
Market Cap
$122.67M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Jun 30, 2024
65.80K19.04K+40.72%
Jun 30, 2023
46.76K-32.46K-40.98%
Jun 30, 2022
79.22K58.67K+285.52%
Jun 30, 2021
20.55K+∞%
Jun 30, 2020
0.00-2.98M-100.00%
Jun 30, 2019
2.98M301.42K+11.24%
Jun 30, 2018
2.68M859.20K+47.12%
Jun 30, 2017
1.82M532.71K+41.28%
Jun 30, 2016
1.29M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis